Caution in Gaucher Disease Genetic Testing
Author Information
Author(s): Justin T Brown, Cora Lahey, Walairat Laosinchai-Wolf, Andrew G Hadd
Primary Institution: Asuragen, Inc.
Hypothesis
Can a multiplexed genetic assay effectively evaluate Gaucher disease alleles?
Conclusion
The study found that a multiplexed assay can identify false heterozygosity in Gaucher disease testing due to gene and pseudogene co-amplification.
Supporting Evidence
- 2% of samples reported as wild-type were found to be heterozygous using the new assay.
- The assay design resolved issues with false heterozygosity.
- Clinical evaluations showed discrepancies with established methods.
Takeaway
Scientists created a new test to check for a disease called Gaucher disease, and they found that some tests were wrong because they mixed up similar genes.
Methodology
The study used a multiplexed suspension array assay to analyze de-identified patient DNA samples for Gaucher disease alleles.
Potential Biases
Potential bias due to the use of de-identified samples and the design of the assay based on existing sequence data.
Limitations
The study's findings may not be generalizable due to the specific population studied and the reliance on available genomic data.
Participant Demographics
The study focused on the Ashkenazi Jewish population, which has a higher prevalence of Gaucher disease.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website